Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Statins market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Statins market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Statins market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Statins products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Statins products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Statins market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Statins development has been the leading industry trend of Statins market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Statins Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Astrovastatin, Fluvastatin, Lovastatin, Pravastatin, Simvastatin, Others |
| By Application Outlook |
Hospitals, Clinics, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
AstraZeneca, Pfizer, GlaxoSmithKline, Novartis International, Merck, Biocon, Concord Biotech, Aurobindo Pharma |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- AstraZeneca
- Pfizer
- GlaxoSmithKline
- Novartis International
- Merck
- Biocon
- Concord Biotech
- Aurobindo Pharma
STATINS Market, By Type
- Astrovastatin
- Fluvastatin
- Lovastatin
- Pravastatin
- Simvastatin
- Others
STATINSMarket, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Statins Market Overview
1.1 Statins Product Overview
1.2 Statins Market Segment by Type
1.2.1 Astrovastatin
1.2.2 Fluvastatin
1.2.3 Lovastatin
1.2.4 Pravastatin
1.2.5 Simvastatin
1.2.6 Others
1.3 Global Statins Market Size by Type
1.3.1 Global Statins Sales and Growth by Type
1.3.2 Global Statins Sales and Market Share by Type (2013-2018)
1.3.3 Global Statins Revenue and Market Share by Type (2013-2018)
1.3.4 Global Statins Price by Type (2013-2018)
2 Global Statins Market Competition by Company
2.1 Global Statins Sales and Market Share by Company (2013-2018)
2.2 Global Statins Revenue and Share by Company (2013-2018)
2.3 Global Statins Price by Company (2013-2018)
2.4 Global Top Players Statins Manufacturing Base Distribution, Sales Area, Product Types
2.5 Statins Market Competitive Situation and Trends
2.5.1 Statins Market Concentration Rate
2.5.2 Global Statins Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Statins Company Profiles and Sales Data
3.1 AstraZeneca
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Statins Product Category, Application and Specification
3.1.3 AstraZeneca Statins Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 Pfizer
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Statins Product Category, Application and Specification
3.2.3 Pfizer Statins Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 GlaxoSmithKline
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Statins Product Category, Application and Specification
3.3.3 GlaxoSmithKline Statins Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 Novartis International
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Statins Product Category, Application and Specification
3.4.3 Novartis International Statins Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 Merck
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Statins Product Category, Application and Specification
3.5.3 Merck Statins Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Biocon
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Statins Product Category, Application and Specification
3.6.3 Biocon Statins Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 Concord Biotech
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Statins Product Category, Application and Specification
3.7.3 Concord Biotech Statins Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 Aurobindo Pharma
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Statins Product Category, Application and Specification
3.8.3 Aurobindo Pharma Statins Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
4 Statins Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Statins Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Statins Sales and Revenue by Regions
4.2.1 Global Statins Sales and Market Share by Regions (2013-2018)
4.2.2 Global Statins Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Statins Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Statins Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Statins Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Statins Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Statins Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Statins Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Statins Application/End Users
5.1 Statins Segment by Application
5.1.1 Hospitals
5.1.2 Clinics
5.2 Global Statins Product Segment by Application
5.2.1 Global Statins Sales by Application
5.2.2 Global Statins Sales and Market Share by Application (2013-2018)
6 Global Statins Market Forecast
6.1 Global Statins Sales, Revenue Forecast (2018-2025)
6.1.1 Global Statins Sales and Growth Rate Forecast (2018-2025)
6.1.1 Global Statins Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Statins Forecast by Regions
6.2.1 North America Statins Sales and Revenue Forecast (2018-2025)
6.2.2 Europe Statins Sales and Revenue Forecast (2018-2025)
6.2.3 Asia-Pacific Statins Sales and Revenue Forecast (2018-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Statins Sales and Revenue Forecast (2018-2025)
6.2.5 Middle East and Africa Statins Sales and Revenue Forecast (2018-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Statins Forecast by Type
6.3.1 Global Statins Sales and Revenue Forecast by Type (2018-2025)
6.3.2 Astrovastatin Gowth Forecast
6.3.3 Fluvastatin Gowth Forecast
6.4 Statins Forecast by Application
6.4.1 Global Statins Sales Forecast by Application (2018-2025)
6.4.2 Global Statins Forecast in Hospitals
6.4.3 Global Statins Forecast in Clinics
7 Statins Upstream Raw Materials
7.1 Statins Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Statins Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
